Emerging Drug Delivery Technologies & Strategies - Players, Pipelines & Partnerships
- Language: English
- 188 Pages
- Published: September 2011
- Region: World
- Your are here:
- Home
- Categories
- Pharmaceuticals and Healthcare
- Pharmaceuticals
- Drug Delivery
U.S. Intranasal Drug Delivery Market
U.S. Intranasal Drug Delivery Market
- Published: March 2006
- Region: World
- Frost & Sullivan
This Frost & Sullivan research service entitled U.S. Intranasal Drug Delivery Market provides pipeline analysis, forecasts and technology overviews. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: allergy, osteoporosis, pain management, vaccines and sexual dysfunction.
What's Included
- Pipeline Analysis
- Market Forecasts
- Technology Overviews
Market Sectors
- Allergy
- Pain Management
- Osteoporosis
- Vaccines
- Sexual Dysfunction
Market Overview
The intranasal drug delivery market is undergoing a fundamental change, shifting from topical to systemic delivered drugs. The last several years have seen allergy corticosteroids dominate the intranasal delivery market but new products in pain management, osteoporosis, vaccines and sexual dysfunction are expected to drive growth and prove systemic drug delivery is the future of revenue generation for this market. New drug delivery technologies and devices are paving the way for peptides and large molecules to be delivered via the nose.
The intranasal drug delivery market is expected to expand the
READ MORE >
1. Executive Summary
- 1. Executive Summary
- - 1. Executive Summary
2. Market Introduction
- 1. Research Scope and Methodology
- - 1. Scope and Segmentation
- - 2. Methodology
- 2. Market Overview
- - 1. Market Engineering Measurements
- - 2. Technology Overview
- - 3. Disease Targets and Applications
- - 4. Challenges and Strategies
- - 5. Market Drivers
3. Competitive Analysis
- 1. Forecasts and Trends
- - 1. Revenue Forecasts
- - 2. Allergy
- - 3. Pain Management
- - 4. Osteoporosis
- - 5. Vaccines
- - 6. Sexual Dysfunction
- - 7. Licensing and Partnership Strategies
- 2. Competitive Analysis
- - 1. Competitive Structure
- - 2. Market Share Analysis
- - 3. Product Analysis - Allergy
- - 4. Product Analysis - Migraine
- - 5. Product Analysis - Osteoporosis
- - 6. Product Analysis - Vaccine
- - 7. Product Analysis - Other
- - 8. Pipeline Analysis
4. Frost & Sullivan Awards
- 1. Frost & Sullivan Awards
- - 1. Company of the Year Award
- - 2. Entrepreneurial Company of the Year Award
- - 3. Business Development Strategy of the Year Award
5. Appendix
- 1. Decision Support Databases
- - 1. Prevalence of Parkinson's Disease
- - 2. Prevalence of Alzheimer's Disease
- - 3. Prevalence of Epilepsy
- - 4. Prevalence of Asthma
- - 5. Pharmaceutical R&D Expenditure
List Of Figures
SEGMENT 2
- Intranasal Drug Delivery Market: Major Device and Formulation Companies (U.S.), 2005 - Intranasal Drug Delivery Market: Impact of Top Industry Challenges (U.S.), 2006-2012 - Intranasal Drug Delivery Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
SEGMENT 3
- Intranasal Drug Delivery Market: Revenue Forecasts (U.S.), 2002-2012 - Intranasal Drug Delivery Market: Market Share by Indication (U.S.), 2005 - Intranasal Drug Delivery Market: Market Share by Indication (U.S.), 2012 - Intranasal Drug Delivery Market: Market Share by Systemic versus Non-Systemic Delivery (U.S.), 2005 - Intranasal Drug Delivery Market: Market Share by Systemic versus Non-Systemic Delivery (U.S.), 2012 - Intranasal Drug Delivery Market: Allergy Revenue Forecasts (U.S.), 2002-2012 - Intranasal Drug Delivery Market: Pain Management Revenue Forecasts (U.S.), 2002-2012 - Intranasal Drug Delivery Market: Osteoporosis Revenue Forecasts (U.S.), 2002-2012 - Intranasal Drug Delivery Market: Vaccine Revenue Forecasts (U.S.), 2002-2012 - Intranasal Drug Delivery Market: Sexual Dysfunction Revenue Forecasts (U.S.), 2002-2012 - Intranasal Drug Delivery Market: Five Questions to Asses Licensing/Partnership Strategies (U.S.), 2005 - Intranasal Drug Delivery Market: Competitive Structure (U.S.), 2005 - Intranasal Drug Delivery Market: Company Market Share by Revenues (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Astelin (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Flonase (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Nasacort AQ (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Nasonex (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Rhinocort Aqua (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Imitrex (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Migranal (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Zomig (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Fortical (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Miacalcin (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - fluMist (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Nascobal (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Butorphanol (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Minirin (U.S.), 2005 - Intranasal Drug Delivery Market: Product Analysis - Stimate (U.S.), 2005 - Intranasal Drug Delivery Market: Pipeline Overview (U.S.), 2005
| Format | Properties | |
|---|---|---|
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Site License | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
| Enterprisewide | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
2008 U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
- Language: English
- 45 Pages
- Published: November 2010
- Region: United States
FROM -
Intranasal Drug Delivery - Global Business Strategic Report
- Language: English
- 441 Pages
- Published: May 2012
- Region: World
FROM -
Transdermal Drug Delivery - Technologies, Markets, and Companies
- Language: English
- 274 Pages
- Published: June 2013
- Region: World
FROM -
Pain Therapeutics - Drugs, Markets and Companies
- Language: English
- 545 Pages
- Published: June 2013
- Region: World
FROM -
Chinese Markets for Drug Delivery System
- Language: English
- Published: November 2012
FROM -
Inhaled Pain Management: Products, Therapeutics, Markets and Forecasts
- Language: English
- Published: May 2011
- Region: World
FROM -
Drug Delivery Technology - Revolutionizing CNS Therapies
- Language: English
- 100 Pages
- Published: December 2007
- Region: World
-
Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017
- Language: English
- 316 Pages
- Published: April 2013
- Region: World
FROM -
Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance
- Language: English
- 69 Pages
- Published: September 2012
- Region: World
FROM
